Beclometasone dry-powder inhalation - Vectura

Drug Profile

Beclometasone dry-powder inhalation - Vectura

Alternative Names: Asmabec Clickhaler; Beclometasone Clickhaler; Beclomethasone Clickhaler

Latest Information Update: 22 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Innovata
  • Developer Vectura
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 19 Jan 2007 Innovata has been acquired by Vectura
  • 14 Jul 2005 Innovata Biomed has merged with ML Laboratories to form Innovata
  • 10 Nov 2003 A study has been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top